Resonance Health (ASX:RHT) Ending Cash Position : A$3.51 Mil (As of Dec. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Resonance Health Ending Cash Position?

Resonance Health's Ending Cash Position for the quarter that ended in Dec. 2024 was A$3.51 Mil.

Resonance Health's quarterly Ending Cash Position increased from Dec. 2023 (A$5.90 Mil) to Jun. 2024 (A$6.86 Mil) but then declined from Jun. 2024 (A$6.86 Mil) to Dec. 2024 (A$3.51 Mil).

Resonance Health's annual Ending Cash Position declined from Jun. 2022 (A$6.78 Mil) to Jun. 2023 (A$6.36 Mil) but then increased from Jun. 2023 (A$6.36 Mil) to Jun. 2024 (A$6.86 Mil).

Resonance Health Ending Cash Position Historical Data

The historical data trend for Resonance Health's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health Ending Cash Position Chart

Resonance Health Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Ending Cash Position

Get a 7-Day Free Trial

6.97

8.86

6.78

6.36

6.86

Resonance Health Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															6.53	6.36	5.90	6.86	3.51

Resonance Health Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Resonance Health's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.363	+	0.492
	=	6.86

Resonance Health's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.855	+	-3.342
	=	3.51

Resonance Health Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Resonance Health's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonance Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

141-143 Burswood Road, Level 1, Burswood, Perth, WA, AUS, 6100

Website

https://www.resonancehealth.com

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

Resonance Health Headlines

No Headlines